Main > ONCOLOGY (**) > Lung>NSCLC>MET>With BRAF V600E>*** > Treatment > Co: CH. N. Dabrafenib+Trametinib

---

Co: CH. N. Dabrafenib+Trametinib's subsections
(*) EU Approval Date: 2017. 04.
(*) USA Approval Date: 2017. 06.23
>Mutation
Companion Diagnostic Test>
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 9
Patent>UpDate: 2018. 10.30.
TradeMark
TradeMark Web-Site

Co: CH. N. Dabrafenib+Trametinib's products
This section has no products